Delivery Order SPE2DB22D1106-SPE2DB25FEJC5

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.65, is for the delivery of Pimecrolimus 1% Cream 100GM, a specialty pharmaceutical product. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,716.19, is for the delivery of pimecrolimus 1% cream to support federal medical and healthcare requirements. The contract is not designated as a set-aside and is therefore open to full and open competition. It is a firm fixed-price delivery order, with a performance period...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,788.52 firm fixed-price contract is for the supply of PIMECROLIMUS 1% CREAM 30GM, a topical medication. This contract is not designated as a set-aside. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,124.57, is for the provision of PIMECROLIMUS 1% CREAM 100GM, a pharmaceutical product. The contract has a period of performance through November 26, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,681.13, is a delivery order for 4568038421 - Pimecrolimus 1% Cream 100GM. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $1,739.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PIMECROLIMUS 1% Cream (30 grams). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PIMECROLIMUS 1% CREAM 100GM, with a ceiling value of $1,242.93 and a completion date of November 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,852.59 firm fixed-price contract is for the delivery of 100-gram tubes of Pimecrolimus 1% cream, a medication used to treat eczema. The award has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pimecrolimus cream. The $1,724.04 contract has a completion date of February 16, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.00 firm fixed-price delivery order is for the supply of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEJC5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream 30GM, a prescription medication, with a ceiling value of $1,017.18. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the broader IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/16/25, 12:27 PM